Preferential involvement of Na+/Ca2+ exchanger type-1 in the brain damage caused by transient focal cerebral ischemia in mice

Nobutaka Morimoto, Satomi Kita, Masamitsu Shimazawa, Hiroko Namimatsu, Kazuhiro Tsuruma, Kazuhide Hayakawa, Kenichi Mishima, Nobuaki Egashira, Takuya Iyoda, Ichiro Horie, Yusuke Gotoh, Katsunori Iwasaki, Michihiro Fujiwara, Toshio Matsuda, Akemichi Baba, Issei Komuro, Kyoji Horie, Junji Takeda, Takahiro Iwamoto, Hideaki Hara

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The Na+/Ca2+ exchanger (NCX), an ion-transporter located in the plasma membrane of neuronal cells, contributes to intracellular Ca2+ homeostasis. Within the brain, three isoforms (NCX1, NCX2, and NCX3) are widely distributed. However, it is not clear to what extent these isoforms are involved in ischemic brain damage in mammals. We therefore used genetically altered mice and isoform-selective NCX inhibitors in a model of transient focal ischemia to investigate the role of each NCX isoform in ischemic brain damage. NCX isoform-mutant mice (NCX1+/-, NCX2+/-, and NCX3+/-) and wild-type mice were subjected to 90min of middle cerebral artery occlusion (MCAO) followed by 24h of reperfusion. One of three NCX inhibitors [SN-6, KB-R7943, or SEA0400 (3 or 10mgkg-1, i.p.)] was administered to ddY mice at 30min before more prolonged (4-h) MCAO followed by 24h of reperfusion. After transient MCAO reperfusion, the cerebral infarcts in NCX1+/- mice, but not those in NCX2+/- or NCX3+/- mice, were significantly smaller than those in wild-type mice. SN-6 and SEA0400, which are more selective for the NCX1 isoform, significantly reduced the infarct volume at 10mg/kg. In contrast, KB-R7943, which is more selective for NCX3, did not. These results suggest that the NCX1 isoform may act preferentially (vs. the NCX2 and NCX3 isoforms) to exacerbate the cerebral damage caused by ischemic insult in mice, and that NCX1-selective inhibitors warrant investigation as a potential therapeutic agents for stroke.

Original languageEnglish
Pages (from-to)186-190
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume429
Issue number3-4
DOIs
Publication statusPublished - Dec 14 2012

Fingerprint

Transient Ischemic Attack
Brain
Protein Isoforms
Middle Cerebral Artery Infarction
Reperfusion
Mammals
Ion exchangers
Cell membranes
Homeostasis
Ischemia
Stroke
Cell Membrane
Ions

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Preferential involvement of Na+/Ca2+ exchanger type-1 in the brain damage caused by transient focal cerebral ischemia in mice. / Morimoto, Nobutaka; Kita, Satomi; Shimazawa, Masamitsu; Namimatsu, Hiroko; Tsuruma, Kazuhiro; Hayakawa, Kazuhide; Mishima, Kenichi; Egashira, Nobuaki; Iyoda, Takuya; Horie, Ichiro; Gotoh, Yusuke; Iwasaki, Katsunori; Fujiwara, Michihiro; Matsuda, Toshio; Baba, Akemichi; Komuro, Issei; Horie, Kyoji; Takeda, Junji; Iwamoto, Takahiro; Hara, Hideaki.

In: Biochemical and Biophysical Research Communications, Vol. 429, No. 3-4, 14.12.2012, p. 186-190.

Research output: Contribution to journalArticle

Morimoto, N, Kita, S, Shimazawa, M, Namimatsu, H, Tsuruma, K, Hayakawa, K, Mishima, K, Egashira, N, Iyoda, T, Horie, I, Gotoh, Y, Iwasaki, K, Fujiwara, M, Matsuda, T, Baba, A, Komuro, I, Horie, K, Takeda, J, Iwamoto, T & Hara, H 2012, 'Preferential involvement of Na+/Ca2+ exchanger type-1 in the brain damage caused by transient focal cerebral ischemia in mice', Biochemical and Biophysical Research Communications, vol. 429, no. 3-4, pp. 186-190. https://doi.org/10.1016/j.bbrc.2012.10.114
Morimoto, Nobutaka ; Kita, Satomi ; Shimazawa, Masamitsu ; Namimatsu, Hiroko ; Tsuruma, Kazuhiro ; Hayakawa, Kazuhide ; Mishima, Kenichi ; Egashira, Nobuaki ; Iyoda, Takuya ; Horie, Ichiro ; Gotoh, Yusuke ; Iwasaki, Katsunori ; Fujiwara, Michihiro ; Matsuda, Toshio ; Baba, Akemichi ; Komuro, Issei ; Horie, Kyoji ; Takeda, Junji ; Iwamoto, Takahiro ; Hara, Hideaki. / Preferential involvement of Na+/Ca2+ exchanger type-1 in the brain damage caused by transient focal cerebral ischemia in mice. In: Biochemical and Biophysical Research Communications. 2012 ; Vol. 429, No. 3-4. pp. 186-190.
@article{efe48928bb2d4bfe91ce19e96c7809bb,
title = "Preferential involvement of Na+/Ca2+ exchanger type-1 in the brain damage caused by transient focal cerebral ischemia in mice",
abstract = "The Na+/Ca2+ exchanger (NCX), an ion-transporter located in the plasma membrane of neuronal cells, contributes to intracellular Ca2+ homeostasis. Within the brain, three isoforms (NCX1, NCX2, and NCX3) are widely distributed. However, it is not clear to what extent these isoforms are involved in ischemic brain damage in mammals. We therefore used genetically altered mice and isoform-selective NCX inhibitors in a model of transient focal ischemia to investigate the role of each NCX isoform in ischemic brain damage. NCX isoform-mutant mice (NCX1+/-, NCX2+/-, and NCX3+/-) and wild-type mice were subjected to 90min of middle cerebral artery occlusion (MCAO) followed by 24h of reperfusion. One of three NCX inhibitors [SN-6, KB-R7943, or SEA0400 (3 or 10mgkg-1, i.p.)] was administered to ddY mice at 30min before more prolonged (4-h) MCAO followed by 24h of reperfusion. After transient MCAO reperfusion, the cerebral infarcts in NCX1+/- mice, but not those in NCX2+/- or NCX3+/- mice, were significantly smaller than those in wild-type mice. SN-6 and SEA0400, which are more selective for the NCX1 isoform, significantly reduced the infarct volume at 10mg/kg. In contrast, KB-R7943, which is more selective for NCX3, did not. These results suggest that the NCX1 isoform may act preferentially (vs. the NCX2 and NCX3 isoforms) to exacerbate the cerebral damage caused by ischemic insult in mice, and that NCX1-selective inhibitors warrant investigation as a potential therapeutic agents for stroke.",
author = "Nobutaka Morimoto and Satomi Kita and Masamitsu Shimazawa and Hiroko Namimatsu and Kazuhiro Tsuruma and Kazuhide Hayakawa and Kenichi Mishima and Nobuaki Egashira and Takuya Iyoda and Ichiro Horie and Yusuke Gotoh and Katsunori Iwasaki and Michihiro Fujiwara and Toshio Matsuda and Akemichi Baba and Issei Komuro and Kyoji Horie and Junji Takeda and Takahiro Iwamoto and Hideaki Hara",
year = "2012",
month = "12",
day = "14",
doi = "10.1016/j.bbrc.2012.10.114",
language = "English",
volume = "429",
pages = "186--190",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3-4",

}

TY - JOUR

T1 - Preferential involvement of Na+/Ca2+ exchanger type-1 in the brain damage caused by transient focal cerebral ischemia in mice

AU - Morimoto, Nobutaka

AU - Kita, Satomi

AU - Shimazawa, Masamitsu

AU - Namimatsu, Hiroko

AU - Tsuruma, Kazuhiro

AU - Hayakawa, Kazuhide

AU - Mishima, Kenichi

AU - Egashira, Nobuaki

AU - Iyoda, Takuya

AU - Horie, Ichiro

AU - Gotoh, Yusuke

AU - Iwasaki, Katsunori

AU - Fujiwara, Michihiro

AU - Matsuda, Toshio

AU - Baba, Akemichi

AU - Komuro, Issei

AU - Horie, Kyoji

AU - Takeda, Junji

AU - Iwamoto, Takahiro

AU - Hara, Hideaki

PY - 2012/12/14

Y1 - 2012/12/14

N2 - The Na+/Ca2+ exchanger (NCX), an ion-transporter located in the plasma membrane of neuronal cells, contributes to intracellular Ca2+ homeostasis. Within the brain, three isoforms (NCX1, NCX2, and NCX3) are widely distributed. However, it is not clear to what extent these isoforms are involved in ischemic brain damage in mammals. We therefore used genetically altered mice and isoform-selective NCX inhibitors in a model of transient focal ischemia to investigate the role of each NCX isoform in ischemic brain damage. NCX isoform-mutant mice (NCX1+/-, NCX2+/-, and NCX3+/-) and wild-type mice were subjected to 90min of middle cerebral artery occlusion (MCAO) followed by 24h of reperfusion. One of three NCX inhibitors [SN-6, KB-R7943, or SEA0400 (3 or 10mgkg-1, i.p.)] was administered to ddY mice at 30min before more prolonged (4-h) MCAO followed by 24h of reperfusion. After transient MCAO reperfusion, the cerebral infarcts in NCX1+/- mice, but not those in NCX2+/- or NCX3+/- mice, were significantly smaller than those in wild-type mice. SN-6 and SEA0400, which are more selective for the NCX1 isoform, significantly reduced the infarct volume at 10mg/kg. In contrast, KB-R7943, which is more selective for NCX3, did not. These results suggest that the NCX1 isoform may act preferentially (vs. the NCX2 and NCX3 isoforms) to exacerbate the cerebral damage caused by ischemic insult in mice, and that NCX1-selective inhibitors warrant investigation as a potential therapeutic agents for stroke.

AB - The Na+/Ca2+ exchanger (NCX), an ion-transporter located in the plasma membrane of neuronal cells, contributes to intracellular Ca2+ homeostasis. Within the brain, three isoforms (NCX1, NCX2, and NCX3) are widely distributed. However, it is not clear to what extent these isoforms are involved in ischemic brain damage in mammals. We therefore used genetically altered mice and isoform-selective NCX inhibitors in a model of transient focal ischemia to investigate the role of each NCX isoform in ischemic brain damage. NCX isoform-mutant mice (NCX1+/-, NCX2+/-, and NCX3+/-) and wild-type mice were subjected to 90min of middle cerebral artery occlusion (MCAO) followed by 24h of reperfusion. One of three NCX inhibitors [SN-6, KB-R7943, or SEA0400 (3 or 10mgkg-1, i.p.)] was administered to ddY mice at 30min before more prolonged (4-h) MCAO followed by 24h of reperfusion. After transient MCAO reperfusion, the cerebral infarcts in NCX1+/- mice, but not those in NCX2+/- or NCX3+/- mice, were significantly smaller than those in wild-type mice. SN-6 and SEA0400, which are more selective for the NCX1 isoform, significantly reduced the infarct volume at 10mg/kg. In contrast, KB-R7943, which is more selective for NCX3, did not. These results suggest that the NCX1 isoform may act preferentially (vs. the NCX2 and NCX3 isoforms) to exacerbate the cerebral damage caused by ischemic insult in mice, and that NCX1-selective inhibitors warrant investigation as a potential therapeutic agents for stroke.

UR - http://www.scopus.com/inward/record.url?scp=84870708982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870708982&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2012.10.114

DO - 10.1016/j.bbrc.2012.10.114

M3 - Article

VL - 429

SP - 186

EP - 190

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3-4

ER -